Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omada Health (OMDA) Cash & Equivalents (2024 - 2025)

Omada Health (OMDA) has disclosed Cash & Equivalents for 2 consecutive years, with $222.0 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 190.65% to $222.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $222.0 million through Dec 2025, up 190.65% year-over-year, with the annual reading at $222.0 million for FY2025, 190.65% up from the prior year.
  • Cash & Equivalents hit $222.0 million in Q4 2025 for Omada Health, up from $198.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $223.1 million in Q2 2025 to a low of $76.4 million in Q4 2024.